Furthermore, CASP1, IL33, IRF9,and SHRAPIN showed high diagnostic accuracy, whereas PYCARD was also identified as a biomarker for NAFLD progression (Fig. 8p). Here, IRF9 is linked to metabolic dysfunction-associated steatotic liver disease.